PATENT CLAIM ANALYSIS

Application Number: 16123926
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
The present invention is drawn to compositions and methods to enhance an immune response in order to prevent or treat infections or hyperproliferative diseases such as cancer. More particularly, the composition is an immunostimulatory intracellular signaling peptide fused directly or indirectly to a peptide that leads to multimerization into complexes of three or more units, where the intracellular signaling peptide must be present in a complex of three or more units in order to stimulate an immune response. Inserting this fusion construct into viruses like HIV-1 or introducing it into dendritic cells or tumor cells is predicted to lead to a positive therapeutic effect in humans, non-human mammals, birds, and fish.

Claim (Index 11):
The virus of  claim 9 , wherein the antigen comprises a tumor antigen, viral antigen, or microbial antigen.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 97.0
- Lexical Diversity: 1.60811
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13635885', '15461336', '16115171', '14424562', '12165360']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7601715568434029
- 35 USC 102 Novelty (BERT): 0.6572878036489228
- Combined Prediction Score: 0.7498831815239548
- Mean Citation Score: 524.399272
- Max Citation Score: 758.5587
- Similarity Product: 590.2532533266664

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test